Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will present at investor conferences during the month of June to discuss the company’s business activities, financial outlook, and current news.

• Robert Perez, President & COO, will present on Wednesday, June 11th, 2014 at 2:00 p.m. Pacific Time, at the Goldman Sachs 35th Annual Global Healthcare Conference being held at Terranea Resort, Rancho Palos Verdes, CA.
• Robert Perez, President & COO, and Michael Tomsicek, SVP & CFO, will present on Wednesday, June 25th, 2014 at 1:30 p.m. Eastern Time, at the 9th Annual JMP Securities Healthcare Conference being held at the Westin New York Grand Central in New York City.

These presentations will be accessible live through Cubist’s website at www.cubist.com in the Investor Relations Conference Calendar section and will remain available there for a period of 30 days after the presentations.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.

Cubist Pharmaceuticals, Inc. INVESTORS: Eileen C. McIntyre, 781-860-8533Vice President, Investor Relations eileen.mcintyre@cubist.com or MEDIA: Julie DiCarlo, 781-860-8063Senior Director, Corporate Communications julie.dicarlo@cubist.com